Head-to-head · WeighScore
Idgie Health vs Rivo Health
By GLP-1 ScorecardUpdated
Score comparison
Idgie Health has the higher recorded score — 75.4/100 to 71.7/100.
Idgie Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes the amount billed today at every rung and names its 503A class — then describes a recurring Membership Fee only in the Terms.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Idgie Health | Rivo Health |
|---|---|---|
| WeighScore | 75.4/100 | 71.7/100 |
| Grade | C | C |
| Site position | #57 | #100 |
| Semaglutide | $149/mo month-to-month ($114 only on a 6-month prepay) | $149/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal) |
| Tirzepatide | $229/mo month-to-month ($171 only on a 6-month prepay) | $199/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal) |
| Coverage | A state-availability page is published | State eligibility unverified; confirm prescribing and dispensing availability for your address |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #57 · C
Strengths
- Every rung carries the figure billed today — $387 at three months, $687 at six on semaglutide — not just a per-month number
- States the pharmacy class plainly: prescriptions ship from a licensed U.S. 503A pharmacy
- Names its operating entity, Feel Better Health Group, LLC, in the page footer rather than only in the Terms
- The plan covers the provider evaluation, all injection supplies, dose titration, unlimited provider messaging and free shipping
- An oral semaglutide and two microdose lines sit beside the injection
What to consider
- Both headlines are the six-month prepay: "From $114" against $149, and "From $171" against $229
- The Terms describe a recurring Membership Fee and exclude the online visit and labs from it, while the pricing page never uses the word and promises no hidden fees
- The same Terms name an Idgie Health Pharmacy Network and a Bask Pharmacy Network without dividing the work between them
- The semaglutide card says "all doses"; the tirzepatide card does not
Site position #100 · C
Strengths
- Advertises semaglutide and tirzepatide injection and oral options
- Starting-price cards disclose an annual-plan condition
- Advertises provider visits, nutrition support and dietitian access
- Current public pages name Rivo Health, Inc. and a Rimo Health clinical network
What to consider
- The $149/$199 labels are annual-plan starting rates; first charge, total obligation and renewal remain unverified
- The selected cancellation and refund agreement has not been verified
- Exact treating practice, dispensing branch and individual state/license eligibility remain unverified
- Bundled service frequency, lab costs, supplied quantity and extra charges need selected-plan confirmation
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.